High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH
The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest.
The cannabis company completed the deal for a 51% interest in Remexian for €26.4 million and has a five-year option for the remaining 49% interest.